Form D — Caspian Therapeutics, Inc.
0001231919-26-001219 · filed Sep 23, 2026
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Reported offering amount
- $50,000,000
- Reported amount sold
- $50,000,000
- Minimum investment
- $0
- Investors
- 43
- Sales commission
- $0
- Finders' fees
- $0
Issuer
- Name
- Caspian Therapeutics, Inc.
- CIK
- 2156247
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2026
- Address
- 4930 DIRECTORS PLACE
SAN DIEGO, CA 92121 - Phone
- (858) 500-8800
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Robert H. Spencer · Executive OfficerSan Diego, CA Find on LinkedIn ↗
-
Troy E. Wilson · DirectorSan Diego, CA Find on LinkedIn ↗
-
Spike Loy · DirectorSan Diego, CA Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗